James Engelhart - Net Worth and Insider Trading

James Engelhart Net Worth

The estimated net worth of James Engelhart is at least $157,640 dollars as of 2024-04-27. James Engelhart is the CFO of Biohaven Pharmaceutical Holding Co Ltd and owns about 11,196 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $157,640. Details can be seen in James Engelhart's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Engelhart has not made any transactions after 2021-12-10 and currently still holds the listed stock(s).

Transaction Summary of James Engelhart

To

James Engelhart Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Engelhart owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .

Click here to see the complete history of James Engelhart’s form 4 insider trades.

Insider Ownership Summary of James Engelhart

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-12-10 Chief Financial Officer

James Engelhart Latest Holdings Summary

James Engelhart currently owns a total of 1 stock. James Engelhart owns 11,196 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of December 10, 2021, with a value of $157,640.

Latest Holdings of James Engelhart

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-12-10 11,196 14.08 157,640

Holding Weightings of James Engelhart


James Engelhart Form 4 Trading Tracker

According to the SEC Form 4 filings, James Engelhart has made a total of 3 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 35,000 shares on December 10, 2021, which brought James Engelhart around $4 Million.

Insider Trading History of James Engelhart

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Engelhart Trading Performance

GuruFocus tracks the stock performance after each of James Engelhart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Engelhart is 9.74%. GuruFocus also compares James Engelhart's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Engelhart within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Engelhart's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Engelhart

Average Return

50.93%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.67 9.74 32.02 50.93 65.51 42.02
Relative Return to S&P 500(%) 4.22 7.5 22.72 43.21 50.29 33.53

James Engelhart Ownership Network

Ownership Network List of James Engelhart

No Data

Ownership Network Relation of James Engelhart


James Engelhart Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

James Engelhart is the Chief Financial Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Officer Matthew Buten .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

James Engelhart Mailing Address

Above is the net worth, insider trading, and ownership report for James Engelhart. You might contact James Engelhart via mailing address: C/o Biohaven Pharmaceutical Holding Comp 234 Church Street New Haven Ct 06510.

Discussions on James Engelhart

No discussions yet.